Photo of a gold mine
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Flynn Gold Ltd (ASX:FG1) has extended a gold-in-soil anomaly at the Grenadier prospect of its Golden Ridge project in Tasmania, with its footprint now measuring more than 1 kilometre north-south and 800 metres east-west.

The company has been conducting soil sampling work at the prospect, which has enabled them to extend the anomaly being extended 300 metres further into the interior of the granodiorite, yielding results of up to 25.3 parts per billion (ppb) and 24.3ppb gold.

Flynn has also found a new gold-in-soil anomaly along the Western contact, around 900 metres to the north of Grenadier, with the ground between these 2 areas never having been subject to soil or rock chip sampling.

Follow-up sampling is planned to assess this anomaly to the north and south.

Managing director and CEO Neil Marston said Flynn was bringing up strong results from its continuing work on site.

“The ongoing soil sampling campaign at the Golden Ridge Project is yielding more highly encouraging results,” he said.

“The footprint of the Grenadier gold-in-soil anomaly has been expanded by a further 300m
to the east. This anomaly is now defined over a 1 kilometre by 800 metre area, highlighting the significant scale potential of this new prospect.

“Ongoing exploration continues to build our understanding of the mineralised system at Golden Ridge, and we look forward to advancing our work programs, including a significant drilling program, across key target areas in the coming months.”

Flynn shares have been trading at 0.4 cents.

Join the discussion: See what HotCopper users are saying about FG1 and be part of the conversations that move the markets.

fg1 by the numbers
More From The Market Online
The Market Online Video

Market Close: ASX 200 rallies as risk appetite returns, but business confidence weakens

The Australian sharemarket finished firmly higher today with the S&P/ASX 200 adding 106.50 points, or 1.18%, to close at 9,136.20.

EVE Health Group signs Australian compounding agreement for rapidly rising Men’s Health issue

EVE Health Group has signed an agreement with Optimal Pharmacy Plus Stafford aimed at the Australian…

Nanoveu’s EMASS signs DigiKey as Global Distributor for ECS-DoT-22

Nanoveu's wholly-owned subsidiary EMASS has signed DigiKey as its global distributor for ECS-DoT-22 system.
The Market Online Video

Wealth Within: Wall Street Tech Sinks While ASX Tech Soars

Wall Street’s technology stocks have been hammered, with the Nasdaq plunging 5.5 per cent in a single session and Nvidia falling more tha…